A cabazitaxel liposome for increased solubility, enhanced antitumor effect and reduced systemic toxicity

The potential side effects of cabazitaxel (CBZ) in the field of cancer treatment have become a great limitation to its further clinical application. Liposomal delivery is a well-established approach to increase the therapeutic index of hydrophobic drugs. In this study, a PEG-modified liposome was de...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Asian J Pharm Sci
Auteurs principaux: Yin, Xiaoyi, Luo, Lihua, Li, Wei, Yang, Jie, Zhu, Chunqi, Jiang, Mengshi, qin, Bing, Yuan, Xiaoling, Yin, Hang, Lu, Yichao, Du, Yongzhong, Chen, Dawei, You, Jian
Format: Artigo
Langue:Inglês
Publié: Shenyang Pharmaceutical University 2019
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7032206/
https://ncbi.nlm.nih.gov/pubmed/32104492
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajps.2018.10.004
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires